Literature DB >> 31999904

Journal Club-COPD2020 Update. Global Initiative for Chronic Obstructive Lung Disease 2020 Report and the Journal of the COPD Foundation Special Edition, Moving to a New Definition for COPD: "COPDGene® 2019".

Ron Balkissoon1.   

Abstract

Entities:  

Keywords:  COPD Genetic Epidemiology; COPDGene; GOLD; Global initiative for chronic Obstructive Lung Dis; chronic obstructive pulmonary disease; copd

Year:  2019        PMID： 31999904      PMCID： PMC7182381          DOI： 10.15326/jcopdf.7.1.2020.0133

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  29 in total

1.  Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.

Authors:  Neil C Barnes; Raj Sharma; Sally Lettis; Peter M A Calverley
Journal:  Eur Respir J       Date:  2016-02-25       Impact factor: 16.671

2.  A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis.

Authors:  Angira Dasgupta; Melanie Kjarsgaard; Dante Capaldi; Katherine Radford; Fernando Aleman; Colm Boylan; Leonard C Altman; Thomas N Wight; Grace Parraga; Paul M O'Byrne; Parameswaran Nair
Journal:  Eur Respir J       Date:  2017-03-15       Impact factor: 16.671

3.  Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.

Authors:  Gary T Ferguson; Klaus F Rabe; Fernando J Martinez; Leonardo M Fabbri; Chen Wang; Masakazu Ichinose; Eric Bourne; Shaila Ballal; Patrick Darken; Kiernan DeAngelis; Magnus Aurivillius; Paul Dorinsky; Colin Reisner
Journal:  Lancet Respir Med       Date:  2018-09-16       Impact factor: 30.700

Review 4.  Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates.

Authors:  Steven D Deas; Nikhil Huprikar
Journal:  Curr Opin Pulm Med       Date:  2018-03       Impact factor: 3.155

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

Authors:  R A Pauwels; A S Buist; P Ma; C R Jenkins; S S Hurd
Journal:  Respir Care       Date:  2001-08       Impact factor: 2.258

6.  Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.

Authors:  Peter M A Calverley; Antonio R Anzueto; Kerstine Carter; Lars Grönke; Christoph Hallmann; Christine Jenkins; Jadwiga Wedzicha; Klaus F Rabe
Journal:  Lancet Respir Med       Date:  2018-04-05       Impact factor: 30.700

7.  Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.

Authors:  Salman H Siddiqui; Ian D Pavord; Neil C Barnes; Alessandro Guasconi; Sally Lettis; Steven Pascoe; Stefano Petruzzelli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-06

8.  Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality.

Authors:  Kendra A Young; Elizabeth A Regan; MeiLan K Han; Sharon M Lutz; Margaret Ragland; Peter J Castaldi; George R Washko; Michael H Cho; Mathew Strand; Douglas Curran-Everett; Terri H Beaty; Russell P Bowler; Emily S Wan; David A Lynch; Barry J Make; Edwin K Silverman; James D Crapo; John E Hokanson; Gregory L Kinney
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

Review 9.  The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease.

Authors:  David M G Halpin
Journal:  Tuberc Respir Dis (Seoul)       Date:  2018-01

10.  Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD.

Authors:  Rashmi Mehta; Eleni Pefani; Misba Beerahee; Noushin Brealey; Helen Barnacle; Ruby Birk; Chang-Qing Zhu; David A Lipson
Journal:  J Clin Pharmacol       Date:  2018-05-15       Impact factor: 3.126
View more
  14 in total

1.  Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.

Authors:  Wassim W Labaki; Meng Xia; Susan Murray; Charles R Hatt; Abdullah Al-Abcha; Michael C Ferrera; Catherine A Meldrum; Lauren A Keith; Craig J Galbán; Douglas A Arenberg; Jeffrey L Curtis; Fernando J Martinez; Ella A Kazerooni; MeiLan K Han
Journal:  Chest       Date:  2020-12-14       Impact factor: 9.410

2.  November 18: World COPD Day 2020. Is it a date to celebrate?

Authors:  Diane Rezende Batista; Liana Sousa Coelho; Suzana Erico Tanni
Journal:  J Bras Pneumol       Date:  2021-01-08       Impact factor: 2.624

3.  Pulmonary hypertension in eosinophilic versus noneosinophilic COPD.

Authors:  Bashar N Alzghoul; Mohammad As Sayaideh; Brian F Moreno; Saminder K Singh; Ayoub Innabi; Raju Reddy; Eric S Papierniak; Hassan M Alnuaimat
Journal:  ERJ Open Res       Date:  2021-03-08

4.  The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis.

Authors:  Tao Yang; Chihua Chen; Zhongyuanlong Chen
Journal:  BMC Pulm Med       Date:  2021-01-20       Impact factor: 3.317

5.  Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis.

Authors:  MeiLan K Han; Gerard J Criner; Mark T Dransfield; David M G Halpin; Christine E Jones; Sally Kilbride; Peter Lange; Sally Lettis; David A Lipson; David A Lomas; Neil Martin; Fernando J Martinez; Robert A Wise; Ian P Naya; Dave Singh
Journal:  ERJ Open Res       Date:  2021-03-08

6.  Ethnic Variance in Prevalence of COPD among Smokers in a Real World Setting.

Authors:  Akshar Aiyer; Salim Surani; Raymond Aguillar; Munish Sharma; Mohammed Ali; Joseph Varon
Journal:  Open Respir Med J       Date:  2020-12-31

7.  ERS International Congress 2020: highlights from the General Pneumology Assembly.

Authors:  Luke Daines; Joren Buekers; Beatriz Abascal Bolado; Janwillem W H Kocks; Guido Vagheggini; Vitalii Poberezhets; Ioannis Vogiatzis; Hilary Pinnock; Lowie E G W Vanfleteren
Journal:  ERJ Open Res       Date:  2021-02-08

8.  Severe outcomes of COVID-19 among patients with COPD and asthma.

Authors:  Erik Soeren Halvard Hansen; Amalie Lykkemark Moeller; Vibeke Backer; Mikkel Porsborg Andersen; Lars Kober; Kristian Kragholm; Christian Torp-Pedersen
Journal:  ERJ Open Res       Date:  2021-01-25

9.  The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD.

Authors:  Toru Shirahata; Hideaki Sato; Sanehiro Yogi; Kaiji Inoue; Mamoru Niitsu; Tomoe Akagami; Machika Soma; Tomohiko Mio; Makoto Nagata; Satoshi Nakae; Yuki Nishida; Shigeho Tanaka; Fuminori Katsukawa; Hidetoshi Nakamura
Journal:  Respir Res       Date:  2021-01-15

10.  Castleman flare or COPD exacerbation- can biomarkers override availability bias?

Authors:  Benjamin B Claxton; Anne E F Dimmock; Rohit Jain; M Bradley Drummond; Rebecca Bascom
Journal:  Respir Med Case Rep       Date:  2020-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.